In vitro antiviral activity and preclinical and clinical resistance profile of miravirsen, a novel anti-hepatitis C virus therapeutic targeting the human factor miR-122 - Ottosen, S; Parsley, T B; Yang, L; Zeh, K; van Doorn, L-J; van der Veer, E (Antimicrob Agents Chemother, 2015)
Available from: